CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 4 Shares withheld for taxes Chief Financial Officer gave up 792 shares (to pay taxes)
- 4 Open-market sale Director sold 1,002 shares at $2.38 ($2,385)
- 4 Shares withheld for taxes SVP, General Counsel gave up 207 shares (to pay taxes)
- 4 Open-market buy SVP, General Counsel bought 5,869 shares at $3.13 ($18,370)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $4.00 ($10,000)
- 4 Open-market buy SVP, General Counsel bought 7,500 shares at $3.99 ($29,925)
- 4 Shares withheld for taxes Chief Executive Officer gave up 207 shares (to pay taxes)
- 4 Grant or award Chief Executive Officer acquired 155,200 shares (grant or award)
- 4 Grant or award SVP, General Counsel acquired 72,750 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 72,750 shares (grant or award)
- 4 Grant or award Director acquired 13,400 shares (grant or award)
- 4 Grant or award Director acquired 13,400 shares (grant or award)
- 4 Grant or award Director acquired 13,400 shares (grant or award)
- 4 Grant or award Director acquired 13,400 shares (grant or award)
- 4 Grant or award Director acquired 13,400 shares (grant or award)
- 4 Grant or award Director acquired 13,400 shares (grant or award)
- 4 Grant or award Director acquired 13,400 shares (grant or award)
- 4 Grant or award Director acquired 13,400 shares (grant or award)
- 4 Shares withheld for taxes SVP, General Counsel gave up 479 shares (to pay taxes)
- 4 Grant or award Chief Financial Officer acquired 12,000 shares (grant or award)
Page 9 of 20 · 394 filings